In the former, excess insulin acts as a potent regulator for driving lipogenic genes expression, which leads to over de novo lipogenesis, impaired mitochondrial fatty acid oxidation and subsequent liver inflammation, whereas the latter promotes lipolysis and secret increased levels of adipokines, free fatty lipids and inflammatory cytokines [25]. The gene discussed is INS; the disease is inflammatory response.